Hess Corp
LSE:0J50
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hess Corp
LSE:0J50
|
US |
|
ATAI Life Sciences NV
F:9VC
|
DE |
|
O
|
Oryzon Genomics SA
SWB:ORN
|
ES |
|
F
|
Fresenius Medical Care AG
SWB:FME
|
DE |
|
WiseTech Global Ltd
ASX:WTC
|
AU |
|
M
|
Mercialys SA
F:M8Y
|
FR |
|
D
|
Diebold Nixdorf Inc
F:DBD
|
US |
|
Afya Ltd
F:1AY
|
BR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0J50's stock price target?
Not Available
0J50 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Hess Corp?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been -4%. The projected CAGR for the next 3 years is 5%.
What is the Operating Income forecast for Hess Corp?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 8%.
What is the Net Income forecast for Hess Corp?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 3 years is 11%.
